Iovance Biotherapeutics Delivers 30% Quarterly Revenue Growth and Achieves Key Clinical Milestones
Market Chameleon (Wed, 25-Feb 11:17 AM)
Iovance Biotherapeutics Delivers 30% Revenue Growth, Expands Amtagvi Adoption, and Secures Fast Track for Pipeline Program
Market Chameleon (Tue, 24-Feb 10:32 AM)
